Table 2.
Outcomes of endoscopic ultrasound-guided hepaticogastrostomy and transmural stenting
| PS (n=109) | cSEMS (n=43) | p-value | |
|---|---|---|---|
| Functional success, yes | 93 (85.3) | 41 (95.3) | 0.149 |
| Punctured bile duct | 0.007 | ||
| B2 | 71 (65.1) | 17 (39.5) | |
| B3 | 38 (34.9) | 26 (60.5) | |
| Tract dilator | <0.001 | ||
| Mechanical | 64 (58.7) | 12 (27.9) | |
| Balloon | 19 (17.4) | 17 (39.5) | |
| Electrocautery | 15 (13.8) | 14 (32.6) | |
| None | 11 (10.1) | 0 (0) | |
| EUS-HGAS, yes | 26 (23.9) | 5 (11.6) | 0.144 |
| Procedure time (min) | 30.0 (8.0–187.0) | 41.0 (15.0–150.0) | 0.125 |
Values are presented as number (%) or median (range).
PS, plastic stent; cSEMS, fully/partially covered self-expandable metallic stent; B2, segment 2 bile duct; B3, segment 3 bile duct; EUS-HGAS, combined endoscopic ultrasound-guided antegrade stenting with endoscopic ultrasound-guided hepaticogastrostomy and transmural stenting.